Chitosan-Collagen Composite for Bone Regeneration
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current bone graft materials, such as demineralized freeze-dried bone allografts, face challenges including immune responses and contamination risks, and existing alternatives like chitosan have short lifespans due to rapid degradation and high expansion rates, limiting their effectiveness in inducing osteogenesis and promoting osseointegration around titanium implants.
Innovation Solution
A chitosan material with a degree of deacetylation between 70% and 90%, combined with a pharmacologically acceptable carrier like collagen, and optionally including antibacterial agents, local anesthetics, or epithelial growth factors, is used to create a biocompatible solution that induces osteogenesis and promotes osseointegration around titanium implants without causing immune responses.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If demineralized freeze-dried bone allografts are used to promote bone formation, then osteogenesis is induced, but immune response and contamination risks occur
Solution Approach 1:
The patent uses chitosan, a biocompatible polysaccharide, to create a synthetic alternative that copies the osteoinductive functions of natural bone grafts without containing proteins that trigger immune responses. The chitosan material serves as a safe substitute that replicates the beneficial bone-forming effects while eliminating contamination risks associated with allografts.
Solution Approach 2:
The patent modifies the chemical composition parameters by using chitosan with specific deacetylation degrees (70-90%) and molecular weights (50-1000 kDa) to achieve optimal osteoinductive properties. By adjusting these parameters, the material maintains bone formation promotion capability while ensuring biocompatibility and avoiding immune responses.
2Reliability
If chitosan is used as a wrapping material to promote cell adhesion and growth, then biocompatibility is improved, but rapid degradation and high expansion rate cause short lifespan
Solution Approach 1:
The patent creates a composite material system by combining chitosan with collagen and hydroxyapatite. This composite structure leverages the biocompatibility and osteoinductivity of chitosan, the structural support and biocompatibility of collagen, and the osteoconductive properties of hydroxyapatite. The synergistic combination maintains beneficial properties while improving material stability and lifespan through the reinforcing effects of collagen and hydroxyapatite.
Solution Approach 2:
The patent applies different materials with specific properties to different functional requirements: chitosan provides biocompatibility and osteoinduction at the cellular interface, collagen provides structural framework and mechanical support, and hydroxyapatite provides osteoconduction and mineralization template. This localized functional assignment optimizes overall performance while addressing the lifespan limitation of pure chitosan.
3Reliability
If autologous bone graft is used for bone defect treatment, then cell activity and biocompatibility are maximized, but limited availability and surgical complexity arise
Solution Approach 1:
The patent creates a synthetic chitosan-based material that copies the osteoinductive and biocompatible properties of autologous bone without requiring harvesting from the patient's own body. This synthetic alternative replicates the beneficial cellular interactions and bone-forming capabilities while eliminating the need for complex donor site surgery and reducing overall surgical complexity.
Solution Approach 2:
The patent employs a readily available, cost-effective chitosan material that can be manufactured and applied without the complexity of harvesting and processing patient-specific bone tissue. The material provides sufficient functionality for its intended use period and can be easily replaced if needed, simplifying the overall treatment approach.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The chitosan-collagen composition effectively induces bone cell regeneration, as evidenced by calcified tissue formation and positive staining for osteopontin and alkaline phosphatase, demonstrating its potential for treating bone defects and enhancing osseointegration without immune reactions or contamination risks.
Implementation Method 1
the osteoinduction means that the bone graft is able to induce mesenchymal cells around it or bone marrow stem cells from the blood to differentiate into osteoprogenitor cells
Implementation Method 2
the chitosan material is a good biocompatibility in order to avoid the immune response in bodies
Implementation Method 3
the collagen of the chitosan material of the present invention is present in the form of a thin membrane and the chitosan is absorbed in the collagen membrane
Implementation Method 4
Treatment of the bone defects with the chitosan material of the present invention can induce the regeneration of bone cells around the bone defects and the bone is repaired in this way
Implementation Method 5
as evidenced by calcified tissue formation and positive staining for osteopontin and alkaline phosphatase
Implementation Method 6
an epithelial growth factor or any combination thereof
Data Source
AI summary
The invention relates to a method of inducing osteogenesis in a subject comprising administrating a chitosan material to the a subject in need of osteogenesis, wherein the chitosan material having a chitosan with a degree of deacetylation at the range of 70%˜90%, and the chitosan is 0.15% by weight of the chitosan material. The method of the present invention can induce bone-forming and promote osseointegration around an implant.